Back to Search
CHRISTOPHER TRIMBLE, M.D./M.B.A.
M.D./M.B.A.
Diagnostic Radiology Physician
NPI: 1568774826IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neuroradiology Physician
Radiology — Neuroradiology
Code: 2085N0700X
D0075241(MD)
Diagnostic Radiology PhysicianPrimary
Radiology — Diagnostic Radiology
Code: 2085R0202X
10229090-1205(UT)
CMS Specialties
PrimaryDIAGNOSTIC RADIOLOGY
Education
UNIVERSITY OF CALIFORNIA, IRVINE, CALIFORNIA COLLEGE OF MEDICINE
Class of 2010
Research & Publications (20)
A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3.
PMID 19118066·Clin Cancer Res·2009
3-trial
Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.
PMID 16400639·Cancer·2006
4-observational
Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype.
PMID 16000566·Clin Cancer Res·2005
8-other
Effectiveness of screening for cervical cancer in an inpatient hospital setting.
PMID 14754701·Obstet Gynecol·2004
8-other
Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe.
PMID 12922140·Vaccine·2003
4-observational
Low-dose radiation enhances therapeutic HPV DNA vaccination in tumor-bearing hosts.
PMID 18815785·Cancer Immunol Immunother·2009
7-preclinical
Combination of treatment with death receptor 5-specific antibody with therapeutic HPV DNA vaccination generates enhanced therapeutic anti-tumor effects.
PMID 18598733·Vaccine·2008
7-preclinical
Pretreatment with cisplatin enhances E7-specific CD8+ T-Cell-mediated antitumor immunity induced by DNA vaccination.
PMID 18483387·Clin Cancer Res·2008
7-preclinical
Cluster intradermal DNA vaccination rapidly induces E7-specific CD8+ T-cell immune responses leading to therapeutic antitumor effects.
PMID 18401437·Gene Ther·2008
7-preclinical
Human papillomavirus vaccination should be offered to young males: Counterpoint.
PMID 18398021·Cancer Epidemiol Biomarkers Prev·2008
8-other
HLA-DQB1*02-restricted HPV-16 E7 peptide-specific CD4+ T-cell immune responses correlate with regression of HPV-16-associated high-grade squamous intraepithelial lesions.
PMID 17438108·Clin Cancer Res·2007
7-preclinical
Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion.
PMID 17974957·Cancer Res·2007
7-preclinical
Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination.
PMID 17234792·Cancer Res·2007
7-preclinical
The PapSpin: a reasonable alternative to other, more expensive liquid-based Papanicolaou tests.
PMID 16628656·Cancer·2006
7-preclinical
Rhodamine-RCA in vivo labeling guided laser capture microdissection of cancer functional angiogenic vessels in a murine squamous cell carcinoma mouse model.
PMID 16457726·Mol Cancer·2006
7-preclinical
Reproducibility of the diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.
PMID 16400640·Cancer·2006
4-observational
A combination of DNA vaccines targeting human papillomavirus type 16 E6 and E7 generates potent antitumor effects.
PMID 16177818·Gene Ther·2006
7-preclinical
Characterization of HLA-A2-restricted HPV-16 E7-specific CD8(+) T-cell immune responses induced by DNA vaccines in HLA-A2 transgenic mice.
PMID 16107858·Gene Ther·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1433 N 1075 W STE 104
FARMINGTON, UT 84025 - Phone
- (801) 298-1300
Quick Facts
- NPI
- 1568774826
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 16
- Publications
- 20
Are you this provider?
Claim Your Profile